drugset / Trial / NCT04053543
CXA-10 Study in Subjects With Pulmonary Arterial Hypertension
Phase 2
Terminated
33 enrolled
Complexa, Inc.
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · collabInnovative Analytics · collabMedpace, Inc. · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 2, multicenter, open-label extension (OLE) of study CXA-10-301, to evaluate the long term safety and efficacy of daily dosing of CXA-10.
Timeline
- Start
- 2019-08-09
- Primary completion
- 2020-08-12
- Completion
- 2020-08-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CXA-10 | Small molecule | 150 mg | — |